The UK-Delaware Dual Structure
UK startups that have raised from US VCs, gone through Y Combinator, or are targeting US market expansion often use a dual structure:
- Delaware C-Corp (US parent) — issues US stock options to US employees and senior team members, requires 409A valuation
- UK Limited Company (operating subsidiary) — handles UK operations, employment, and can issue EMI options to UK employees
This structure allows the startup to optimise equity compensation for both US and UK employees using the most tax-efficient instrument for each jurisdiction.
EMI Schemes vs US Options: Key Differences
| UK EMI Options | US Delaware Options (409A) | |
|---|---|---|
| Governing law | HMRC / UK tax law | IRC Section 409A (US federal) |
| Granted by | UK Limited Company | Delaware C-Corp |
| Valuation required | HMRC pre-approval (AMV agreement) | Independent 409A appraisal |
| Tax benefit | CGT rate (10% with ER) on disposal | ISO: long-term CGT if held 2yr; NSO: ordinary income at exercise |
| Employee limit | £250,000 per employee | No per-employee limit for NSOs |
| Company limit | £3 million total EMI options | No limit |
When UK Startups Need a 409A?
A UK startup needs a 409A valuation when:
- They have incorporated a Delaware C-Corp (as parent or subsidiary)
- They plan to grant stock options from that Delaware entity
- The option recipients are subject to US tax law (US employees, US-based contractors)
If the startup has only a UK entity and only UK-based employees receiving EMI options, they do not need a 409A — but they do need an HMRC Actual Market Value (AMV) agreement for EMI purposes.
Post-Brexit Considerations
Post-Brexit, UK startups are increasingly targeting US expansion earlier in their lifecycle. The UK's relatively startup-friendly environment (R&D tax credits, SEIS/EIS schemes, EMI options) combined with a Delaware C-Corp for US investor access is now a common and well-understood structure.
UK startups going through this transition typically need their first 409A when they incorporate the Delaware entity and before they issue their first US option grants — often at the time of a Series A round from a US lead investor.